PapersFlow Research Brief
Dermatology and Skin Diseases
Research Guide
What is Dermatology and Skin Diseases?
Dermatology and Skin Diseases is the medical specialty focused on the diagnosis, treatment, and prevention of conditions affecting the skin, hair, nails, and mucous membranes.
The field encompasses 96,984 published works. The Dermatology Life Quality Index (DLQI), introduced by Finlay and Khan (1994), provides a simple questionnaire for assessing the impact of skin diseases on patients' lives in routine clinical practice. Diagnostic criteria for atopic dermatitis were established by Hanifin and Rajka (1980) to standardize identification of this common inflammatory skin condition.
Research Sub-Topics
Atopic Dermatitis Epidemiology
Atopic dermatitis epidemiology investigates global prevalence, risk factors, and temporal trends using cohort and cross-sectional studies. Researchers analyze environmental and genetic determinants.
Skin Microbiome Dysbiosis
Skin microbiome dysbiosis examines microbial community shifts in diseases like atopic dermatitis via metagenomics. Researchers link Staphylococcus aureus overgrowth to barrier dysfunction.
Dermatology Life Quality Index
Dermatology Life Quality Index (DLQI) validates patient-reported outcomes measuring skin disease impact on quality of life. Researchers develop derivatives and apply in clinical trials.
Gut-Skin Axis in Dermatology
Gut-skin axis in dermatology explores how intestinal microbiota influences skin immunity and inflammation. Researchers study probiotic interventions and fecal microbiota links to diseases.
Diagnostic Criteria for Atopic Dermatitis
Diagnostic criteria for atopic dermatitis refine clinical features like Hanifin-Rajka for research and practice. Researchers validate tools across populations and age groups.
Why It Matters
Dermatology impacts patient quality of life, as measured by the DLQI, which Finlay and Khan (1994) developed for clinical use across various skin diseases affecting 120 patients studied. Atopic dermatitis affects up to 20% of children and 3% of adults worldwide, according to Nutten (2015), straining healthcare resources. Recent developments include FDA breakthrough therapy designation for litifilimab (BIIB059) targeting BDCA2 in cutaneous lupus erythematosus, and DermaSensor's $16M funding for AI-powered skin cancer detection devices. Alphyn raised $25M for Phase 2b trials in atopic dermatitis and molluscum contagiosum.
Reading Guide
Where to Start
"Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use" by Finlay and Khan (1994) is the starting point, as it introduces a straightforward, widely used tool (5339 citations) for understanding patient impacts across skin diseases.
Key Papers Explained
Finlay and Khan (1994) established the DLQI for quality-of-life assessment, which complements Hanifin and Rajka (1980)'s diagnostic criteria for atopic dermatitis (5059 citations). Williams et al. (2000) expanded on atopic dermatitis epidemiology, building to Nutten (2015)'s global risk factor analysis (3000 citations). Grice and Segre (2011) connected these via the skin microbiome (2973 citations), while Belkaid and Hand (2014) linked microbiota to inflammation (5030 citations).
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent preprints highlight epithelial barrier diseases in seborrheic dermatitis (Meng et al., 2025) and cross-modal imaging for histologic features. FDA designated litifilimab for cutaneous lupus; Alphyn advances Phase 2b atopic dermatitis trials. GitHub tools like derm-foundation enable ML for skin image tasks.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Dermatology Life Quality Index (DLQI)-a simple practical measu... | 1994 | Clinical and Experimen... | 5.3K | ✕ |
| 2 | Diagnostic Features of Atopic Dermatitis | 1980 | Acta Dermato Venereolo... | 5.1K | ✓ |
| 3 | Role of the Microbiota in Immunity and Inflammation | 2014 | Cell | 5.0K | ✓ |
| 4 | Atopic Dermatitis | 2000 | — | 4.6K | ✕ |
| 5 | Gut microbiome modulates response to anti–PD-1 immunotherapy i... | 2017 | Science | 4.4K | ✓ |
| 6 | Dermatology in General Medicine. | 1987 | Annals of Internal Med... | 3.8K | ✕ |
| 7 | International Study of Asthma and Allergies in Childhood (ISAA... | 1995 | European Respiratory J... | 3.7K | ✓ |
| 8 | Worldwide variation in prevalence of symptoms of asthma, aller... | 1998 | The Lancet | 3.4K | ✕ |
| 9 | Atopic Dermatitis: Global Epidemiology and Risk Factors | 2015 | Annals of Nutrition an... | 3.0K | ✓ |
| 10 | The skin microbiome | 2011 | Nature Reviews Microbi... | 3.0K | ✓ |
In the News
FDA Grants Breakthrough Therapy Designation to ...
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to litifilimab (BIIB059), an investigational monoclonal antibody targeting blood dendritic cell antigen 2 (BDC...
Biogen's Litifilimab Receives FDA Breakthrough Therapy ...
* FDA Breakthrough Therapy Designation is granted to expedite the development and review of drugs for serious diseases
DermaSensor Secures $16M to Scale AI-Powered Skin ...
*MIAMI, FL –October 2, 2025*/ EINPresswire.com/ DermaSensor Inc., a medical device technology company transforming skin cancer detection for frontline care, today announced it has raised $16 millio...
Alphyn Closes $25M Oversubscribed Series B Financing ...
*Financing funds the global Phase 2b clinical trial in atopic dermatitis and Phase 2 clinical program in molluscum contagiosum*
Dermatology Foundation Receives Generous $1M Grant ...
disorders. This new DF research award funds groundbreaking investigations into these critical conditions providing each selected investigative researchers will receive $100,000 annually for three y...
Code & Tools
The **Skin Ontology Tool** is a utility tool designed to assist in translating dermatology datasets to ICD-10 and ICD-11 codes. The tool processes ...
This repository contains the code to reproduce all evaluations in the paper "Towards Foundation Models for Digital Dermatology". ## Usage Run`mak...
Derm Foundation is a machine learning (ML) model that produces embeddings based on dermatology images. The embeddings can be used to efficiently bu...
A comprehensive deep learning-based system for the automated classification of skin diseases, leveraging convolutional neural networks to assist he...
LesNet (Lesion Net) is an open-source project for AI-based skin lesion detection. It aims to create a reliable tool and foster community involvemen...
Recent Preprints
JAMA Dermatology – The Latest in the Science of Skin ...
Epithelial Barrier Diseases Among Adult Patients With Seborrheic Dermatitis Sabrina Meng, BS; Ronald Berna, MD; Ole Hoffstad, MS; et al Original Investigation \| November 5, 2025 online Novemb...
JMIR Dermatology
As an open-access journal, we are read by clinicians and patients alike and focus on applied science reporting the design and evaluation of health innovations and emerging technologies in dermatolo...
Journal of Investigative Dermatology: Home Page
Journal of Investigative Dermatology (SID) The Journal of Investigative Dermatology (JID) publishes high impact reports describing original research related to all aspects of cutaneous biology an...
Journal of the American Academy of Dermatology: Home Page
The Official Publication of the American Academy of Dermatology *The Journal of the American Academy of Dermatology*(JAAD), the official scientific publication of the American Academy of Dermatolog...
Lifestyle Medicine for Dermatologic Disease
Lifestyle medicine is an emerging field that uses targeted behavioral interventions to prevent and manage chronic diseases. This review examines how its six pillars; nutrition, physical activity, s...
Latest Developments
Recent developments in dermatology and skin diseases research as of February 2026 include advances in biologic therapies, personalized laser treatments, AI-assisted diagnostics, regenerative dermatology, and improved interventions for hair and scalp conditions (London Dermatology Centre, 2026; Dermatology Times, 2026).
Sources
Frequently Asked Questions
What is the Dermatology Life Quality Index?
The Dermatology Life Quality Index (DLQI) is a simple practical questionnaire for routine clinical use to assess the impact of skin diseases and treatments on patients' lives. Finlay and Khan (1994) developed it based on responses from 120 patients with different skin diseases. It enables standardized measurement of quality-of-life impairment in dermatology practice.
What are the diagnostic features of atopic dermatitis?
Hanifin and Rajka (1980) defined diagnostic features of atopic dermatitis in their seminal paper. These criteria standardize identification of the condition's clinical presentation. The work has 5059 citations, reflecting its foundational role.
How does the skin microbiome relate to skin diseases?
Grice and Segre (2011) reviewed the skin microbiome's composition and dynamics in 'The skin microbiome'. It influences immunity and inflammation, as explored by Belkaid and Hand (2014). Dysbiosis contributes to conditions like atopic dermatitis.
What is the global prevalence of atopic dermatitis?
Nutten (2015) reported atopic dermatitis affects up to 20% of children and up to 3% of adults worldwide. It presents with a wide spectrum of symptoms and imposes a burden on healthcare and quality of life. Risk factors include genetic and environmental elements.
How does the gut microbiome affect melanoma treatment?
Gopalakrishnan et al. (2017) showed in 'Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients' that favorable gut bacteria enhance responses to PD-1 blockade. Antibiotic use correlates with poor outcomes. This links microbiome to dermatologic oncology.
What tools exist for digital dermatology?
GitHub repositories like Digital-Dermatology/skin_ontology_tool map datasets to ICD-10/11 codes for dermatology data standardization. Google-Health/derm-foundation provides ML embeddings from skin images for efficient AI model building. These support tasks like skin disease classification.
Open Research Questions
- ? How can epithelial barrier defects in seborrheic dermatitis be precisely quantified among adult patients?
- ? What histologic features can cross-modal imaging non-invasively identify in skin conditions?
- ? How do lifestyle medicine pillars like nutrition and sleep management quantitatively improve outcomes in specific dermatologic diseases?
- ? Which gut microbiome compositions optimally predict anti-PD-1 responses in melanoma patients?
- ? How do small-scale foundation models perform in digital dermatology tasks compared to larger models?
Recent Trends
Works count stands at 96,984 with no specified 5-year growth.
Preprints from November 2025 cover epithelial barrier diseases in seborrheic dermatitis (Meng et al.) and noninvasive histologic imaging.
News notes FDA breakthrough for litifilimab in cutaneous lupus , DermaSensor's $16M for AI skin cancer detection (2025), and Alphyn's $25M for atopic dermatitis trials (2025).
2026Dermatology Foundation granted $1M for research awards starting 2026.
Research Dermatology and Skin Diseases with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Dermatology and Skin Diseases with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.